Vivani Medical与诺和诺德达成协议 评估用于慢性体重管理的微型超长效司美格鲁肽植入物Npm-139

美股速递
Jul 07

Vivani Medical已与诺和诺德签署一项协议,旨在评估其研发的Npm-139。该产品是一种微型、超长效的司美格鲁肽植入物,专为慢性体重管理而设计。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10